Overjoyed to finally be able to share our latest publication @Nature in which we show that boosters targeted against the Omicron variant alone can engage rare naive B cells targeting variant-specific epitopes. 📖Check it out!📖⬇️ https://t.co/8DFWkdmnJE
Congratulations to Dr. Neil Anderson, Dr. Carey-Ann Burnham, Dr. Bijal Parikh and Dr. Ali Ellebedy on receiving Dean's Impact Awards from @WUSTLmed. Read the full story here: https://t.co/tHwTIshXg4 #wusmpathimm#PathTwitter
A new paper from the Ellebedy Lab shows that to be effective, #COVID19 boosters should target variants widely different from the virus's original strain. Read more about the research in this @WUSTLmed article: https://t.co/1L3YwaMjNy @SameerMalladi@als_wafaa#wusmpathimm
Latest publication out of the Ellebedy Lab showing de novo B cell responses to variant vaccines in humans. Led by @als_wafaa and @SameerMalladi . Check it out! https://t.co/AeYWvbcphn
.@NIH highlights the work of @TheBcellArtist @WUSTLmed on how the #COVID19 immune response improves for months after vaccination. https://t.co/YyhJXiU0ls
@WUSTLImmuno Journal Club this week led by @als_wafaa and Dr. Hongzhen Hu @WashUanesthesia on @ImmunityCP article ‘Interleukin-6 produced by enteric neurons regulates the number and phenotype of microbe-responsive regulatory T cells in the gut’ from the Benoist Lab.
Influenza disappeared from most of the world in the past 18 months, when influenza transmission was suppressed by the anti-COVID public health measures. But now influenza B is spreading again in mainland China and detections are increasing each week (1/9)